Tonix Pharmaceuticals (TNXP) on Watch Following Presentation of TNX-102 SL Data in PTSD
Tweet Send to a Friend
Tonix Pharmaceuticals (Nasdaq: TNXP) shares are on watch Monday after the company presented efficacy results of a retrospective analysis of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE